Clinical trial reportRMD openPublished
Nipocalimab and certolizumab combination therapy in participants with active rheumatoid arthritis despite prior treatment with advanced therapies: results from the phase 2a DAISY-RA study
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- RMD open
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Arthritis, Rheumatoid; Antirheumatic Agents; Treatment Outcome; Drug Therapy, Combination; Adult; Aged; Middle Aged; Female; Male; Antibodies, Monoclonal, Humanized; Certolizumab Pegol
- PubMed ID
- 41781163
- PubMed Central ID
- PMC13266242
- Open access
- Yes, open
- Added to directory
- Source checked